InvestorsHub Logo
Followers 10
Posts 781
Boards Moderated 0
Alias Born 11/15/2006

Re: Turney post# 7122

Saturday, 05/30/2015 8:15:32 PM

Saturday, May 30, 2015 8:15:32 PM

Post# of 43714
Also,
Immunotherapy with the anti-PD-1 antibody pembrolizumab decreased the size of tumors by 30 percent or more in 24.8 percent of 132 patients with recurrent or metastatic head and neck cancer. That's nearly twice as effective as the current preferred treatment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News